Evidence map›Paper›PMID 10794713›Full record

ArticleThe Biochemical journal2000

Identification and expression analysis of leptin-regulated immediate early response and late target genes.

W Waelput, A Verhee, D Broekaert, S Eyckerman, J Vandekerckhove, J H Beattie, J Tavernier

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. The Leptin Receptor Complex: Heavier Than Expected?Frontiers in endocrinology · 2017
    Review
  4. Article
  5. Article
  6. Review
  7. Cell signals influencing hepatic fibrosis.International journal of hepatology · 2012
    Article
  8. Article
  9. Metallothionein and the biology of aging.Ageing research reviews · 2011
    Review
  10. The Cdk5/p35 kinases modulate leptin-induced STAT3 signaling.Journal of molecular neuroscience : MN · 2009
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

W WaelputFlanders Interuniversity Institute for Biotechnology, Department VIB09, Medical Protein Research, Faculty of Medicine, University of Ghent, Belgium.
A Verhee
D Broekaert
S Eyckerman
J Vandekerckhove
J H Beattie
J Tavernier
Vlaams Instituut voor Biotechnologie · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using PC12 cells as an in vitro model system, we have identified a series of transcripts induced through activation of the leptin receptor. On the basis of kinetic studies, two distinct gene sets could be discerned: signal transducer and activator of transciption-3 (STAT-3), suppressor of cytokine signalling-3 (SOCS-3), MT-II (metallothionein-II), the serine/threonine kinase fibroblast-growth-factor-inducible kinase (Fnk) and modulator recognition factor (MRF-1), which are immediate early response genes, and pancreatitis-associated protein I (PAP I), squalene epoxidase, uridine diphosphate glucuronosyltransferase and annexin VIII, which are late induced target genes. At late time points a strong co-stimulation with beta-nerve growth factor or with the adenylate cyclase activator forskolin was observed. To assess the validity of the PC12-cell model system, we examined the effect of leptin administration on the gene transcription of STAT-3, MT-II, Fnk and PAP I in vivo. Leptin treatment of leptin-deficient ob/ob mice increased the STAT-3, SOCS-3, MT-II and Fnk mRNA, and MT-I protein levels in liver, whereas, in jejunum, expression of PAP I mRNA was down-regulated. Furthermore, administration of leptin to starved wild-type mice enhanced the expression of MT-II and Fnk mRNA in liver, but decreased MT-II and PAP I mRNA expression in jejunum. These findings may help to explain the obese phenotype observed in some colonies of MT-I- and MT-II-null mice and/or the observation that leptin protects against tumour-necrosis-factor toxicity in vivo.

Indexed as

Antigens, NeoplasmBiomarkers, TumorCell Cycle ProteinsGene Expression RegulationLectins, C-TypeProteinsReceptors, Cell SurfaceRepressor ProteinsTranscription FactorsAcute-Phase ProteinsAnimalsCarrier ProteinsColforsinDNA-Binding ProteinsDrug SynergismFemaleAcute-Phase ProteinsAntigens, NeoplasmBiomarkers, TumorCarrier ProteinsCell Cycle ProteinsColforsinDNA-Binding ProteinsLectins, C-TypeLEPR protein, humanLeptinleptin receptor, mouseMetallothioneinNerve Growth FactorPancreatitis-Associated ProteinsPLK3 protein, humanPlk3 protein, mousePlk3 protein, ratPolo-like KinasesProteinsProtein Serine-Threonine KinasesReceptors, Cell SurfaceReceptors, LeptinREG3A protein, humanReg3b protein, mouseReg3b protein, ratRepressor ProteinsRNA, MessengerSOCS3 protein, humanSocs3 protein, mouseSocs3 protein, ratSTAT3 protein, humanStat3 protein, mouseStat3 protein, ratSTAT3 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling ProteinsTrans-ActivatorsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID10794713
PMCPMC1221035
OpenAlexW1964181541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.